Literature DB >> 7309331

Control of body weight by lower gut signals.

H S Koopmans, A Sclafani.   

Abstract

The importance of the terminal ileum in the control of food intake and body weight was studied in rats made obese by VMH knife cuts and in lean controls. In the first study, 35 rats had either jejunoileal bypass, antibiotic infusion into the bypassed segment, resection of the bypassed segment of sham operation. All three experimental treatments reduced food intake and produced large and statistically equivalent weight losses compared to the sham surgery control. Apparently, physiological signals or bacterial toxins arising in the bypassed segment are not essential to the loss of body weight. In the second study, 38 rats had either 5 or 10 cm segments of the terminal ileum transposed to mid-duodenum or upper jejunum or served as surgical controls. As in the previous study, the experimental rats reduced their food intake and sustained a substantial loss of body weight. Stimulation of the terminal ileum with nutrient-rich chyme was sufficient to cause most of the weight loss seen after jejunoileal bypass.

Entities:  

Mesh:

Year:  1981        PMID: 7309331

Source DB:  PubMed          Journal:  Int J Obes


  13 in total

Review 1.  Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies.

Authors:  M Fried; G Ribaric; J N Buchwald; S Svacina; K Dolezalova; N Scopinaro
Journal:  Obes Surg       Date:  2010-06       Impact factor: 4.129

Review 2.  Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery.

Authors:  David E Cummings; Joost Overduin; Karen E Foster-Schubert; Molly J Carlson
Journal:  Surg Obes Relat Dis       Date:  2007 Mar-Apr       Impact factor: 4.734

Review 3.  Gut hormones as potential new targets for appetite regulation and the treatment of obesity.

Authors:  Benjamin C T Field; Alison M Wren; Dunstan Cooke; Stephen R Bloom
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 4.  Bariatric surgery: a history of empiricism, a future in science.

Authors:  John C Alverdy; Vivek Prachand; Brody Flanagan; William A Thistlethwaite; Mark Siegler; Marc Garfinkel; Peter Angelos; Shailesh Agarwal; Heena Santry
Journal:  J Gastrointest Surg       Date:  2008-11-13       Impact factor: 3.452

5.  Ileal brake activation: macronutrient-specific effects on eating behavior?

Authors:  M van Avesaat; F J Troost; D Ripken; H F Hendriks; A A M Masclee
Journal:  Int J Obes (Lond)       Date:  2014-06-24       Impact factor: 5.095

6.  Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities.

Authors:  Rohit Kohli; Michelle Kirby; Kenneth D R Setchell; Pinky Jha; Kori Klustaitis; Laura A Woollett; Paul T Pfluger; William F Balistreri; Patrick Tso; Ronald J Jandacek; Stephen C Woods; James E Heubi; Matthias H Tschoep; David A D'Alessio; Noah F Shroyer; Randy J Seeley
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-01       Impact factor: 4.052

Review 7.  Obesity surgery and gut-brain communication.

Authors:  Hans-Rudolf Berthoud; Andrew C Shin; Huiyuan Zheng
Journal:  Physiol Behav       Date:  2011-02-24

8.  Ileal Transposition Increases Pancreatic β Cell Mass and Decreases β Cell Senescence in Diet-Induced Obese Rats.

Authors:  Chang Ho Ahn; Eun Hye Choi; Tae Jung Oh; Young Min Cho
Journal:  Obes Surg       Date:  2020-05       Impact factor: 4.129

9.  Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat.

Authors:  Bethany P Cummings; April D Strader; Kimber L Stanhope; James L Graham; Jennifer Lee; Helen E Raybould; Denis G Baskin; Peter J Havel
Journal:  Gastroenterology       Date:  2010-03-10       Impact factor: 22.682

10.  The role of the gut hormone GLP-1 in the metabolic improvements caused by ileal transposition.

Authors:  Shrawan Gaitonde; Rohit Kohli; Randy Seeley
Journal:  J Surg Res       Date:  2011-05-18       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.